Research and Development

Innovation Clinical Trials Clinical Research Cost Reduction Investment Market Trends Health Innovations Collaboration Collaborations Investment Trends

3 ARTICLES

4w ago

C-BRAIN Releases Open‑Source AI Toolbox to Speed Alzheimer’s Research

The suite gives approved researchers tools to combine published and unpublished data under a federated, scientist-in-the-loop model to shorten discovery cycles.

10 ARTICLES

2mo ago

Argentina Secures US$8 Billion Clinical Research Pledge From Multinational Drugmakers

6 ARTICLES

3mo ago

Boehringer’s Dual-Agonist Survodutide Cuts Body Weight by Up to 16.6% in Phase III Trial

5 ARTICLES

3mo ago

Mexico, Pfizer Sign Deal to Produce mRNA Covid Vaccines in Toluca by Winter 2027-2028

5 ARTICLES

5mo ago

Novo’s Triple-Hormone Obesity Drug UBT251 Hits 19.7% Mean Weight Loss in China Phase 2

5 ARTICLES

5mo ago

Brazil Weighs Tirzepatide Access: New Bill Seeks Farmácia Popular Coverage as Patent‑Break Push Advances

9 ARTICLES

5mo ago

Brazil Government Opposes Patent Breaks for Weight-Loss Pens After House Fast-Tracks Bill

4 ARTICLES

6mo ago

Sanofi’s Venglustat Notches Gaucher Type 3 Phase 3 Win, Misses Fabry Pain Endpoint

6 ARTICLES

6mo ago

India Notifies Risk-Based Overhaul of Drug R&D Rules

6 ARTICLES

8mo ago

Okava Launches First GLP-1 Implant Trial for Overweight Cats

3 ARTICLES

8mo ago

FDA Issues Draft Guidance Easing Primate Tests for Some Antibody Drugs

9 ARTICLES

9mo ago

First New Antimalarial in Decades Tops 97% Cure in Phase III as Novartis Seeks Approval

7 ARTICLES

last yr.

Scientists Convert Plastic Waste Into Paracetamol With 92% Yield

3 ARTICLES

last yr.

SPARC Shares Plunge Nearly 20% After Failed Phase 2 Vibozilimod Trials

6 ARTICLES

last yr.

Roche’s New Antibiotic Against Acinetobacter baumannii Advances to Phase III Trials

5 ARTICLES

last yr.

FDA Launches Immediate Plan to Replace Animal Testing with Human-Relevant Methods

10 ARTICLES

last yr.

FDA Launches Roadmap to Phase Out Animal Testing in Drug Development

Research and Development

C-BRAIN Releases Open‑Source AI Toolbox to Speed Alzheimer’s Research

Argentina Secures US$8 Billion Clinical Research Pledge From Multinational Drugmakers

Boehringer’s Dual-Agonist Survodutide Cuts Body Weight by Up to 16.6% in Phase III Trial

WHO Prequalifies First Malaria Treatment for Newborns

EU Drug Panel Backs Sanofi’s Cenrifki for Non‑Relapsing SPMS

OpenAI Launches GPT-Rosalind, a Biology-Tuned AI for Drug Discovery

Mexico, Pfizer Sign Deal to Produce mRNA Covid Vaccines in Toluca by Winter 2027-2028

Novo’s Triple-Hormone Obesity Drug UBT251 Hits 19.7% Mean Weight Loss in China Phase 2

Brazil Weighs Tirzepatide Access: New Bill Seeks Farmácia Popular Coverage as Patent‑Break Push Advances

Brazil Government Opposes Patent Breaks for Weight-Loss Pens After House Fast-Tracks Bill

Never miss stories about

Research and Development

Sanofi’s Venglustat Notches Gaucher Type 3 Phase 3 Win, Misses Fabry Pain Endpoint

India Notifies Risk-Based Overhaul of Drug R&D Rules

Okava Launches First GLP-1 Implant Trial for Overweight Cats

FDA Issues Draft Guidance Easing Primate Tests for Some Antibody Drugs

First New Antimalarial in Decades Tops 97% Cure in Phase III as Novartis Seeks Approval

Scientists Convert Plastic Waste Into Paracetamol With 92% Yield

SPARC Shares Plunge Nearly 20% After Failed Phase 2 Vibozilimod Trials

Roche’s New Antibiotic Against Acinetobacter baumannii Advances to Phase III Trials

FDA Launches Immediate Plan to Replace Animal Testing with Human-Relevant Methods

FDA Launches Roadmap to Phase Out Animal Testing in Drug Development

Never miss stories about

Research and Development